Patents Assigned to Ventaira Pharmaceuticals, Inc.
  • Publication number: 20080308095
    Abstract: The invention is directed to devices and methods for electrohydrodynamic (EHD) aerosolization of liquids utilizing a dissociated discharge electrode and an electric field shield disposed between the nozzle and the discharge electrode. Preferred embodiments are designed as inhalers suitable for administration of therapeutic compounds to the respiratory tract of a patient, preferably the lungs.
    Type: Application
    Filed: November 16, 2006
    Publication date: December 18, 2008
    Applicant: Ventaira Pharmaceuticals, Inc.
    Inventors: Gregory A. Trees, Jason Chungyin Fong
  • Patent number: 7141542
    Abstract: The invention is directed to a stable formulation of a biologically active protein useful for aerosol delivery to the respiratory tract of a patient in need of treatment comprising: (a) a carrier liquid comprising from about 10% to from about 100% V/V water and from about 0% to from about 90% V/V of an organic liquid; (b) a biologically effective amount of a protein suspended or dissolved in a carrier liquid; and (c) a stabilizing effective amount of a derivatized carbohydrate stabilizing agent suspended or dissolved in said carrier liquid. The stable formulations of the invention may optionally contain about 0.1% to about 5.0% W/V of a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: November 28, 2006
    Assignee: Ventaira Pharmaceuticals, Inc.
    Inventors: Siu Man L. Cowan, Vincent McGinniss, Donna T. Palmer, Steven M. Risser, Richard S. Brody
  • Patent number: 7025754
    Abstract: A container closure device for facilitating withdrawal of a liquid from a collapsible sealed packet is disclosed. The device includes a needle guide and a septum retainer wherein the needle guide is fixable to an outer face of the packet and the septum retainer is fixable to an inner face of the packet in alignment with the needle guide. The needle guide includes a tube for receiving a needle and insures proper alignment of the needle. The septum retainer includes a septum chamber having a septum disposed therein.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 11, 2006
    Assignee: Ventaira Pharmaceuticals, Inc.
    Inventors: George C. Proicou, Richard D. Peters, David Rust Busick, Theodore Robert Adams
  • Patent number: 6827559
    Abstract: A micropump comprising a pump body including a fluid inlet channel, a fluid outlet channel and pumping reservoir, the fluid inlet channel and the fluid outlet channel communicating with the pumping reservoir, a diaphragm covering the pumping reservoir, a piezoelectric strip actuator attached to the diaphragm such that by applying a voltage to the actuator, the diaphragm can be raised or lowered relative to the pumping chamber, a valve on the inlet channel and the outlet channel, the valve opening and closing the inlet and the outlet channel in response to the raising and lowering of the diaphragm.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: December 7, 2004
    Assignee: Ventaira Pharmaceuticals, Inc.
    Inventors: Richard D. Peters, David Rust Busick, Theodore Robert Adams
  • Patent number: 6820652
    Abstract: A multi-channel valve having a valve seat, a valve seal, and valve seal housing. The assembly of the apparatus creates a plurality of inlet, exit, and cross channels enclosed by elastomeric portions of a valve seal. The elastomeric portions of the valve seal create bounded distensible chambers. Pressure exerted by a fluid in excess of the cracking pressure of the seal tends to distend portions of the elastomeric seal and allow flow through and into the chambers. When inflow pressure falls, the elastic rebound of the elastomeric portions of the seal tends to expel fluid from the valve without backflow. Cross channel capacity allows mixing of the fluids. The plurality of, and differentials between, chambers allows one fluid to completely purge the valve of other fluids. The valve may be configured with additional backflow prevention capacities, such as channel variations, secondary elastomeric members, and variations in primary membrane properties.
    Type: Grant
    Filed: December 24, 2002
    Date of Patent: November 23, 2004
    Assignee: Ventaira Pharmaceuticals, Inc.
    Inventors: Peter A. Gaydos, Theodore Robert Adams
  • Patent number: D547051
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: July 24, 2007
    Assignee: Ventaira Pharmaceuticals, Inc.
    Inventors: Karl Dallas Kirk, III, Theodore Robert Adams